RSS-Feed abonnieren
DOI: 10.1055/s-0031-1271668
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Glucose Homeostasis Abnormalities Assessed by an OGTT in Coronary Artery Disease Patients During Admission and Follow-up at Ambulation
Publikationsverlauf
received 15.11.2010
first decision 19.12.2010
accepted 12.01.2011
Publikationsdatum:
03. März 2011 (online)

Abstract
Background: Most non diabetic patients admitted with acute coronary syndrome (ACS) demonstrate an abnormality in glucose homeostasis. It was claimed that an oral glucose tolerance test (OGTT) undertaken during the admission is a good indicator of the patient's glycemic status.
Aim: The aim of this study was to examine the reproducibility of OGTT based dysglycemic diagnosis during the acute admission and during an ambulatory visit in patients with ischemic heart disease (IHD).
Methods: We have repeated an OGTT on 29 patients with IHD who had been tested with OGTT during hospitalization for ACS.
Results: In 20 of the 29 (69%) patients the OGTT results improved on the repeated ambulatory test. This improvement was evident in the post-prandial glucose level yet not in the fasting levels. There were no significant differences in beta-cell function or in insulin sensitivity between the OGTTs as assessed by HOMA calculations. However there was tendency for improvement in insulin sensitivity at 2 h when assessed by the SI120 formula.
Conclusions: In this pilot study we found that impaired post-prandial glucose control in patients with ACS improves when retested at ambulation. Therefore, it is probably better to perform the OGTT as an ambulatory test and not during the acute admission for defining abnormalities in glucose homeostasis of patients with ACS.
Key words
coronary disease - diabetes mellitus - impaired glucose tolerance - impaired fasting glucose - insulin resistance
References
- 1
Avignon A, Boegner C, Mariano-Goulart D. et al .
Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or
post oral glucose-load state.
International Journal of Obesity.
1999;
23
512-517
MissingFormLabel
- 2
Bartnik M, Rydén L, Ferrari R. et al .
The prevalence of abnormal glucose regulation in patients with coronary artery disease
across Europe: The Euro Heart Survey on diabetes and the heart.
European Heart Journal.
2004;
25
1880-1890
MissingFormLabel
- 3
Cavalot F, Petrelli A, Traversa M. et al .
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting
blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the
San Luigi Gonzaga diabetes study.
Journal of Clinical Endocrinology and Metabolism.
2006;
91
813-819
MissingFormLabel
- 4
Choi KM, Lee KW, Kim SG. et al .
Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction
patients without a previous diagnosis of diabetes mellitus.
Journal of Clinical Endocrinology and Metabolism.
2005;
90
175-180
MissingFormLabel
- 5
Davidson MB.
Counterpoint: The oral glucose tolerance test is superfluous.
Diabetes Care.
2002;
25
1883-1884
MissingFormLabel
- 6
Gerstein HC.
Dysglycaemia: a cardiovascular risk factor.
Diabetes Research and Clinical Practice.
1998;
40
(suppl)
S9-S14
MissingFormLabel
- 7
Ilany J, Marai I, Cohen O. et al .
Glucose abnormalities in cardiac intensive care unit patients.
Acta Diabetologica.
2009;
46
209-216
MissingFormLabel
- 8
Ko GT, Chan JC, Woo J. et al .
The reproducibility and usefulness of the oral glucose tolerance test in screening
for diabetes and other cardiovascular risk factors.
Annals of Clinical Biochemistry.
1998;
35
62-67
MissingFormLabel
- 9
Kosiborod M, Rathore SS, Inzucchi SE. et al .
Admission glucose and mortality in elderly patients hospitalized with acute myocardial
infarction: implications for patients with and without recognized diabetes.
Circulation.
2005;
111
3078-3086
MissingFormLabel
- 10
McAlister FA, Majumdar SR, Blitz S. et al .
The relation between hyperglycemia and outcomes in 2 471 patients admitted to the
hospital with community-acquired pneumonia.
Diabetes Care.
2005;
28
810-815
MissingFormLabel
- 11
McCowen KC, Malhotra A, Bistrian BR.
Stress-Induced hyperglycemia.
Critical Care Clinics.
2001;
17
107-124
MissingFormLabel
- 12
Mooy JM, Grootenhuis PA, de Vries H. et al .
Intra-individual variation of glucose, specific insulin and proinsulin concentrations
measured by two oral glucose tolerance tests in a general Caucasian population: the
Hoorn Study.
Diabetologia.
1996;
39
298-305
MissingFormLabel
- 13
Norhammar A, Tenerz Å, Nilsson G. et al .
Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis
of diabetes mellitus: a prospective study.
Lancet.
2002;
359
2140-2144
MissingFormLabel
- 14
Ramachandran A, Chamukuttan S, Immaneni S. et al .
High incidence of glucose intolerance in Asian-Indian subjects with acute coronary
syndrome.
Diabetes Care.
2005;
28
2492-2496
MissingFormLabel
- 15
Rathmann W, Icks A, Haastert B. et al .
Undiagnosed diabetes mellitus among patients with prior myocardial infarction.
Zeitschrift für Kardiologie.
2002;
91
620-625
MissingFormLabel
- 16
Srinivas-Shankar U, Somauroo JD, Delduca AM. et al .
Temporal change in glucose tolerance in non-ST-elevation myocardial infarction.
Diabetes Research and Clinical Practice.
2008;
82
310-316
MissingFormLabel
- 17
Tai ES, Goh SY, Lee JJM. et al .
Lowering the criterion for impaired fasting glucose: impact on disease prevalence
and associated risk of diabetes and ischemic heart disease.
Diabetes Care.
2004;
27
1728-1734
MissingFormLabel
- 18
Tenerz Å, Norhammar A, Silveira A. et al .
Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial
infarction without previously known diabetes.
Diabetes Care.
2003;
26
2770-2776
MissingFormLabel
- 19
Tominaga M, Eguchi H, Manaka H. et al .
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired
fasting glucose: The Funagata diabetes study.
Diabetes Care.
1999;
22
920-924
MissingFormLabel
Correspondence
Dr. J. IlanyMD
Institute of Endocrinology
Sheba Medical Center
Tel-Hashomer
52621 Israel
Telefon: +972/3/5305 382
Telefon: +972/5/2385 2461
Fax: +972/3/6357 018
eMail: jacob.ilani@sheba.health.gov.il